Author Question: The cost of group health insurance is lower than if an individual buys a policy on his own because ... (Read 358 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
The cost of group health insurance is lower than if an individual buys a policy on his own because
 
  A) moral hazard costs of a group tend to move to a low average.
  B) insuring a group eliminates the problem of buyers having more information than the seller.
  C) it is easier for the company to deny claims from a large group.
  D) the problem of adverse selection is reduced.

Question 2

What are the transactions that the balance of payments accounts record?
 
  What will be an ideal response?


mcabuhat

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

D

Answer to Question 2

The current account records payments for imports of goods and services from abroad, receipts from exports of goods and services sold abroad, net interest income paid abroad, and net transfers abroad (such as foreign aid payments). The capital and financial account records foreign investment in the U.S. minus U.S. investment abroad. Any statistical discrepancy is also recorded in the capital account. The official settlements account records the change in U.S. official reserves.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library